BARWON HEALTH
- Country
- ๐ฆ๐บAustralia
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 5K
- Market Cap
- -
Clinical Trials
22
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)โข Click on a phase to view related trials
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 120
- Registration Number
- NCT06481163
- Locations
- ๐ฆ๐บ
Barwon Health, Geelong, Victoria, Australia
๐ฆ๐บRoyal Melbourne Hospital, Melbourne, Australia
A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas
- Conditions
- Gastrointestinal Neuroendocrine Carcinomas
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 4
- Registration Number
- NCT02215447
- Locations
- ๐ฆ๐บ
Royal North Shore Hospital, St Leonards, New South Wales, Australia
๐ฆ๐บBarwon Health, Geelong, Victoria, Australia
๐ฆ๐บRoyal Melbourne Hospital, Parkville, Victoria, Australia
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 60
- Registration Number
- NCT01830244
- Locations
- ๐ฆ๐บ
Bankstown Lidcome Hospital, Bankstown, New South Wales, Australia
๐ฆ๐บRoyal North Shore Hospital, Sydney, New South Wales, Australia
๐ฆ๐บBarwon Health, Geelong, Victoria, Australia
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 7
- Registration Number
- NCT01486459
- Locations
- ๐ฆ๐บ
Barwon Health, Geelong, Victoria, Australia
๐ฆ๐บPeter MacCallum Cancer Centre, Moorabbin, Victoria, Australia
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment
- Conditions
- Prostate Cancer
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 107
- Registration Number
- NCT00823771
- Locations
- ๐ฆ๐บ
Andrew Love Cancer Centre, Geelong, Victoria, Australia
- Prev
- 1
- 2
- Next